Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

BOEHRINGER INGELHEIM

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 25
  • 0 comments

FDA approve TELMISARTAN

Comment Full text

BOEHRINGER INGELHEIM

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 23
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; TELMISARTAN

Comment Full text

CHATTEM SANOFI

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 22
  • 0 comments

FDA approve FEXOFENADINE HYDROCHLORIDE

Comment Full text

NOVARTIS PHARMS CORP

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 24
  • 0 comments

FDA approve brolucizumab-dbll

Comment Full text

SUN PHARMA GLOBAL

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 23
  • 0 comments

FDA approve TILDRAKIZUMAB-ASMN

Comment Full text

ALKEM LABS LTD

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 26
  • 0 comments

FDA approve EZETIMIBE; SIMVASTATIN

Comment Full text

UPJOHN

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 26
  • 0 comments

FDA approve LATANOPROST

Comment Full text

ALCON

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 27
  • 0 comments

FDA approve NAPHAZOLINE HYDROCHLORIDE; PHENIRAMINE MALEATE

Comment Full text

HERITAGE LIFE

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 24
  • 0 comments

FDA approve CLOZAPINE

Comment Full text

PFIZER

  • FDA Approval
  • Dec. 21, 2022, 16:25 UTC
  • 28
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; SPIRONOLACTONE

Comment Full text
  • Previous
  • 915
  • 916
  • 917
  • 918
  • 919
  • Next

Search

News categories

  • Technical Exchange News(12263)
  • Event(6229)
  • SEC News(267570)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(155698)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin